NextCure, Inc. Common Stock (NXTC) is a publicly traded Healthcare sector company. As of July 15, 2026, NXTC trades at $5.65 with a market cap of $7.87M and a P/E ratio of -0.33. NXTC moved +183.03% today. Year to date, NXTC is -53.63%; over the trailing twelve months it is +34.29%. Its 52-week range spans $1.55 to $15.96. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces NXTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NXTC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $5.65 |
| Market Cap | $7.87M |
| P/E Ratio | -0.33 |
| EPS | $-19.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.96 |
| 52-Week Low | $1.55 |
| Volume | 108.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-55.84M |
| Gross Margin | 0.00% |
2 analysts cover NXTC: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.